Reply to "The perceived efficacy of hydroxychloroquine in observational studies : the results of the confounding effects of 'goals of care'"
| Errataetall: |
CommentOn: Int J Antimicrob Agents. 2021 Apr;57(4):106308. - PMID 33609717 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
International journal of antimicrobial agents - 57(2021), 4 vom: 19. Apr., Seite 106307 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dauby, Nicolas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.04.2021 Date Revised 31.03.2024 published: Print-Electronic CommentOn: Int J Antimicrob Agents. 2021 Apr;57(4):106308. - PMID 33609717 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijantimicag.2021.106307 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321684109 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321684109 | ||
| 003 | DE-627 | ||
| 005 | 20240331232535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijantimicag.2021.106307 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1358.xml |
| 035 | |a (DE-627)NLM321684109 | ||
| 035 | |a (NLM)33609720 | ||
| 035 | |a (PII)S0924-8579(21)00037-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dauby, Nicolas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply to "The perceived efficacy of hydroxychloroquine in observational studies |b the results of the confounding effects of 'goals of care'" |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.04.2021 | ||
| 500 | |a Date Revised 31.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Int J Antimicrob Agents. 2021 Apr;57(4):106308. - PMID 33609717 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Hautekiet, Joris |e verfasserin |4 aut | |
| 700 | 1 | |a Catteau, Lucy |e verfasserin |4 aut | |
| 700 | 1 | |a Montourcy, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Van Beckhoven, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Bottieau, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Goetghebeur, Els |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of antimicrobial agents |d 1991 |g 57(2021), 4 vom: 19. Apr., Seite 106307 |w (DE-627)NLM090678974 |x 1872-7913 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2021 |g number:4 |g day:19 |g month:04 |g pages:106307 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijantimicag.2021.106307 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2021 |e 4 |b 19 |c 04 |h 106307 | ||